CVSGF(CVSGF)
CVSGF
No analyst ratings available
No analyst price targets available for CVSGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.05B | $1.10B | $1.13B |
| Low | $994M | $1.04B | $1.09B | $1.11B |
| High | $1.01B | $1.06B | $1.11B | $1.13B |
| EBITDA Avg | $170M | $178M | $187M | $191M |
| Low | $168M | $176M | $184M | $188M |
| High | $172M | $179M | $188M | $192M |
| EBIT Avg | $85M | $89M | $93M | $95M |
| Low | $84M | $88M | $92M | $94M |
| High | $86M | $89M | $94M | $96M |
| Net Income Avg | $93M | $102M | $112M | $115M |
| Low | $91M | $100M | $110M | $113M |
| High | $93M | $103M | $113M | $116M |
| EPS Avg | $1.29 | $1.42 | $1.56 | $1.60 |
| Low | $1.27 | $1.40 | $1.54 | $1.58 |
| High | $1.30 | $1.43 | $1.58 | $1.62 |
| Analysts (Rev / EPS) | 9 / 1 | 3 / 1 | 4 / 1 | 5 / 1 |